Skip to main content

Auto trading meets the OTC market

OPEN PLATFORM: OTC DERIVATIVES TRADING

As any buy- side firm involved in the OTC derivatives market will tell you, there is not an abundance of products available to automate their confirmation operations. But, argues Scrittura’s John Lewis, this is likely to change in the foreseeable future as firms and vendors start turning their attention to the buy side in what has up until now been a sell-side centric phenomenon.

Current OTC trading systems have been created with the expectation that there is a dedicated staff available for

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

The market’s most valuable asset?

DTCC’s Tim Lind writes that using data effectively can provide the intelligence needed to improve investment performance, reduce risk, and inform strategic decision‑making.

Navigating the MarketAxess ICE storm

The Waters Wrap: Most of the discussion surrounding ICE’s MarketAxess buy has focused more on benefits for the front office than the data possibilities.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here